Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05223387 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tissue Level vs Bone Level Implants for Plural Restorations : a Multicentre Randomised Controlled Trial

Study acronym: IBERICA
StatusActive, Not Recruiting
PhaseNot applicable
SponsorAnthogyr
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 19, 2025 (before its estimated July 18, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Re-verified, no change to tracked fieldsv4
  2. Notable Primary completion date: Aug 20, 2024 to Jul 18, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Aug 20, 2026 to Jul 18, 2027
    • Site details revised at 3 of 3 sites
    v3
  3. Minor Start date changed from estimate of Feb 15, 2022 to Mar 30, 2022v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
2 trials monitored
See all monitored trials
Anthogyr Axiom Tissue-Level implants and corresponding Multi-Unit abutments recently enriched the available product range for dental surgeons. This Post-Market Clinical Follow-Up study aims at confirming the safety and performance of these products. The comparison with similar Anthogyr Axiom Bone-level implants will provide additional information on the effect of platform-switching in bone level maintenance for single and two-piece design at the implant level.
Trial Details
NCT Number NCT05223387
Lead Sponsor Anthogyr
Conditions
(from sponsor)
Dental Implants, Edentulous
Related terms Mouth, Edentulous
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov